References
- Acarturk, F. (1989). Preparation of a prolonged-release tablet formulation of diclofenac sodium. 1. Using chitosan. Pharmazie, 44, 547–549., [PUBMED], [INFOTRIEVE]
- Al-Angary, A. A., Khidr, S. H., Mahrous, G. M., & Gouda, M. W. (1990). In-vitro dissolution and in-vivo absorption of marketed sustained release theophylline preparations. International Journal of Pharmaceutics, 65, R5–R8., [CROSSREF]
- Banker, G. S., Anderson, N. R. (1986). Tablets. In: L. Lachman, H. A. Liberman, & J. L. Kanig (eds.), The Theory and Practice of Industrial Pharmacy (pp. 293–345). Philadelphia: Lea and Febiger.
- Bayomi, M. A. (2003). Influence of polymers weight ratio and pH of polymers solution on the characteristics of chitosan-carboxymethyl cellulose microspheres containing theophylline. Bollettino Chimico Farmaceutico, 142, 336–342., [PUBMED], [INFOTRIEVE], [CSA]
- Bayomi, M. A., Al-Suwayeh, S. A., & El-Helw, A. R. (2001). Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy, 27, 499–506., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Berger, J., Reist, M., Mayer, J. M., Felt, O., Peppas, N. A., & Gurny, R. (2004). Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics, 57, 19–34., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bernkop-Schnurch, A., Schuhbauer, H., Clausen, A. E., & Hanel, R. (2004). Development of a sustained release dosage form for alpha-lip acid. I. Design and in vitro evaluation. Drug Development and Industrial Pharmacy, 30, 27–34., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hejazi, R., & Amiji, N. (2003). Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbil. Pharmaceutical Development and Technology, 8, 253–262., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hirano, S., Ohe, Y., & One, H. (1976). Selective N-acetylation of chitosan. Carbohydrate Research, 47, 315–320., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Illum, L. (1998). Chitosan and its uses as a pharmaceutical excipient. Pharmaceutical Research, 15, 1326–1331., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jacobs, M. H., Senior, R. M., & Kessler, G. (1976). Clinical experience with theophylline. Relationships between dosage, serum concentration, and toxicity. JAMA, 235, 1983–1986., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jain, S. K., Chourasia, M. K., Sabitha, M., Jain, R., Jain, R., Jain, A. K., Ashawat, M., & Jha, A. K. (2003). Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Delivery, 10, 169–177., [PUBMED], [INFOTRIEVE]
- Lacey, L. F., Keene, O. N., Duquesnoy, C., & Bye, A. (1994). Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies. Journal of Pharmaceutical Sciences, 83, 212–215., [PUBMED], [INFOTRIEVE]
- Miyazaki, S., Nakayama, A., Oda, M., Takada, M., & Atwood, D. (1994). Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biological and Pharmaceutical Bulletin, 17, 745–747., [PUBMED], [INFOTRIEVE], [CSA]
- Mura, P., Zerrouk, N., Mennini, N., Maestrelli, F., & Chemtob, C. (2003). Development and characterization of naproxen-chitosan solid system with improved drug dissolution properties. European Journal of Pharmaceutical Sciences, 19, 67–75., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Niaga, T., Sawayanagi, Y., & Nambu, N. (1984). Application of chitin and chitosan to pharmaceutical preparations. In: J. P. Zikakis (Ed.), Chitin, Chitosan and Related Enzymes (pp. 21–40). New York: Academic Press, Inc.
- Ozbas-Turan, S., Akbuga, J., & Aral, C. (2002). Controlled release of interleukin-2 from chitosan microspheres. Journal of Pharmaceutical Sciences, 91, 1245–1251., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Roldo, M., Hornof, M., Caliceti, P., & Bernkop-Schnurch, A. (2004). Mucoadhesive thiolated chitosan as platforms for oral controlled drug delivery: synthesis and ion vitro evaluation. European Journal of Pharmaceutics and Biopharmaceutics, 57, 115–121., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sabnis, S., Rege, P., & Block, L. H. (1997). Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharmaceutical Development and Technology, 2, 243–255., [PUBMED], [INFOTRIEVE], [CSA]
- Sawayanagi, Y., Nambu, N., & Nagi, T. (1982). Directly compressed tablets containing chitin or chitosan in addition to manitol. Chemical and Pharmaceutical Bulletin, 30, 4216
- Sinha, V. R., & Kumria, R. (2002). Binders for colon specific drug delivery: an in vitro evaluation. International Journal of Pharmaceutics, 249, 23–31., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Skaugrud, O., Hagen, A., Borgersen, B., & Dornish, M. (1999). Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnology and Genetic Engineering Reviews, 16, 23–40., [PUBMED], [INFOTRIEVE], [CSA]
- Tapia, C., Costa, E., Terraza, C., Munita, A. M., & Azdani-Pedram, M. (2002). Study of the prolonged release of theophylline from polymeric matrices based on grafted chitosan with acrylamide. Pharmazie, 57, 744–749., [PUBMED], [INFOTRIEVE]
- Upadrashta, S., Katikaneni, P., & Nuessle, N. (1992). Chitosan as a tablet binder. Drug Development and Industrial Pharmacy, 15, 1701–1708.